| pubmed-article:9710021 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9710021 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:9710021 | lifeskim:mentions | umls-concept:C0011923 | lld:lifeskim |
| pubmed-article:9710021 | lifeskim:mentions | umls-concept:C0014556 | lld:lifeskim |
| pubmed-article:9710021 | lifeskim:mentions | umls-concept:C0024485 | lld:lifeskim |
| pubmed-article:9710021 | lifeskim:mentions | umls-concept:C1553628 | lld:lifeskim |
| pubmed-article:9710021 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:9710021 | pubmed:dateCreated | 1998-9-8 | lld:pubmed |
| pubmed-article:9710021 | pubmed:abstractText | To compare the phosphorous metabolite ratios in the mesial temporal lobe of healthy volunteers (n = 20) with the corresponding ratios in patients with temporal lobe epilepsy (n = 30) using 31P NMR spectroscopic imaging and to lateralize the seizure focus in temporal lobe epilepsy patients using various phosphorous metabolite ratios-phosphocreatine to inorganic phosphate (PCr/Pi), PCr to adenosine triphosphate (PCr/gamma-ATP), and (gamma-ATP/Pi)--and to compare with clinical lateralization results. | lld:pubmed |
| pubmed-article:9710021 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9710021 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9710021 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9710021 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9710021 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9710021 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:9710021 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9710021 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9710021 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9710021 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9710021 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9710021 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:9710021 | pubmed:issn | 0028-3878 | lld:pubmed |
| pubmed-article:9710021 | pubmed:author | pubmed-author:SimovPP | lld:pubmed |
| pubmed-article:9710021 | pubmed:author | pubmed-author:ElgavishG AGA | lld:pubmed |
| pubmed-article:9710021 | pubmed:author | pubmed-author:MasonG FGF | lld:pubmed |
| pubmed-article:9710021 | pubmed:author | pubmed-author:KuznieckyR... | lld:pubmed |
| pubmed-article:9710021 | pubmed:author | pubmed-author:HetheringtonH... | lld:pubmed |
| pubmed-article:9710021 | pubmed:author | pubmed-author:ChuW JWJ | lld:pubmed |
| pubmed-article:9710021 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9710021 | pubmed:volume | 51 | lld:pubmed |
| pubmed-article:9710021 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9710021 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9710021 | pubmed:pagination | 472-9 | lld:pubmed |
| pubmed-article:9710021 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:9710021 | pubmed:meshHeading | pubmed-meshheading:9710021-... | lld:pubmed |
| pubmed-article:9710021 | pubmed:meshHeading | pubmed-meshheading:9710021-... | lld:pubmed |
| pubmed-article:9710021 | pubmed:meshHeading | pubmed-meshheading:9710021-... | lld:pubmed |
| pubmed-article:9710021 | pubmed:meshHeading | pubmed-meshheading:9710021-... | lld:pubmed |
| pubmed-article:9710021 | pubmed:meshHeading | pubmed-meshheading:9710021-... | lld:pubmed |
| pubmed-article:9710021 | pubmed:meshHeading | pubmed-meshheading:9710021-... | lld:pubmed |
| pubmed-article:9710021 | pubmed:meshHeading | pubmed-meshheading:9710021-... | lld:pubmed |
| pubmed-article:9710021 | pubmed:meshHeading | pubmed-meshheading:9710021-... | lld:pubmed |
| pubmed-article:9710021 | pubmed:meshHeading | pubmed-meshheading:9710021-... | lld:pubmed |
| pubmed-article:9710021 | pubmed:meshHeading | pubmed-meshheading:9710021-... | lld:pubmed |
| pubmed-article:9710021 | pubmed:meshHeading | pubmed-meshheading:9710021-... | lld:pubmed |
| pubmed-article:9710021 | pubmed:meshHeading | pubmed-meshheading:9710021-... | lld:pubmed |
| pubmed-article:9710021 | pubmed:meshHeading | pubmed-meshheading:9710021-... | lld:pubmed |
| pubmed-article:9710021 | pubmed:meshHeading | pubmed-meshheading:9710021-... | lld:pubmed |
| pubmed-article:9710021 | pubmed:meshHeading | pubmed-meshheading:9710021-... | lld:pubmed |
| pubmed-article:9710021 | pubmed:meshHeading | pubmed-meshheading:9710021-... | lld:pubmed |
| pubmed-article:9710021 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9710021 | pubmed:articleTitle | Lateralization of human temporal lobe epilepsy by 31P NMR spectroscopic imaging at 4.1 T. | lld:pubmed |
| pubmed-article:9710021 | pubmed:affiliation | Center for NMR Research and Development, University of Alabama at Birmingham, 35294-0006, USA. | lld:pubmed |
| pubmed-article:9710021 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9710021 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9710021 | lld:pubmed |
